|
SFRS5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.014400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.084650E-01 |
| Normal-vs-Stage2 |
3.110400E-02 |
| Normal-vs-Stage3 |
7.574300E-04 |
| Normal-vs-Stage4 |
5.182200E-03 |
| Stage1-vs-Stage2 |
3.857600E-01 |
| Stage1-vs-Stage3 |
1.072220E-02 |
| Stage1-vs-Stage4 |
9.938200E-03 |
| Stage2-vs-Stage3 |
3.269800E-01 |
| Stage2-vs-Stage4 |
2.385200E-01 |
| Stage3-vs-Stage4 |
6.508800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.622100E-02 |
| Normal-vs-AfricanAmerican |
2.299800E-01 |
| Normal-vs-Asian |
1.418430E-03 |
| Caucasian-vs-AfricanAmerican |
3.546400E-01 |
| Caucasian-vs-Asian |
5.082200E-02 |
| AfricanAmerican-vs-Asian |
1.985700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.187900E-02 |
| Normal-vs-Female |
7.223900E-02 |
| Male-vs-Female |
9.474200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.007790E-01 |
| Normal-vs-Extreme_Weight |
1.174000E-01 |
| Normal-vs-Obese |
2.836300E-02 |
| Normal-vs-Extreme_Obese |
2.978500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.511200E-01 |
| Normal_Weight-vs-Obese |
8.121200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.206000E-01 |
| Extreme_Weight-vs-Obese |
6.251400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.644600E-01 |
| Obese-vs-Extreme_Obese |
4.138400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.152200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.416000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.048470E-02 |
| Normal-vs-Age(81-100Yrs) |
9.185500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.791000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.508200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.243200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.374400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.908200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.186800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.657800E-01 |
| Normal-VS-Type2 PRCC |
2.05679999998321E-06 |
| Normal-VS-KIRP CIMP |
3.156900E-03 |
| Normal-VS-Unclassified PRCC |
1.965920E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.29989999664693E-08 |
| Type1 PRCC-VS-KIRP CIMP |
9.424200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.642400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.448200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.896200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.268640E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.758900E-04 |
| Normal-vs-N1 |
4.107600E-02 |
| Normal-vs-N2 |
2.20520000038249E-07 |
| N0-vs-N1 |
4.821600E-01 |
| N0-vs-N2 |
1.690240E-02 |
| N1-vs-N2 |
2.596300E-04 |
|
|
